• Guaraná reduced total cholesterol and LDL-C in hyperlipidemic rats.
H I G H L I G H T S
• Guaraná reduced total cholesterol and LDL-C in hyperlipidemic rats.
• Guarana prevents memory impairment induced by hyperlipidemia.
• Anxiety-like behaviors is not altered either by hyperlipidemia or by guarana, caffeine or simvastatin.
• Guarana prevented the alterations induced by hyperlipidemia in AChE activity in the hippocampus.
• Guarana could be used as adjuvant therapy in hyperlipidemic patients. a b s t r a c t a r t i c l e i n f o
Introduction
Hyperlipidemia and hypercholesterolemia are major risk factors in the incidence and pathogenesis of degenerative diseases including atherosclerosis, obesity, cardiovascular disease and Alzheimer's disease (AD) [1] [2] [3] . Cholesterol plays crucial role in the development and normal functioning of the central nervous system (CNS). It maintains neuronal plasticity [4] [5] [6] , transports synaptic vesicle along microtubules [7] and participates in neurotransmitter release [6] . The brain is rich in cholesterol and is the major component in the specialized membranes of myelin; present in glial cells and localized in lipoprotein particles [8] . Peripheral and brain cholesterol pools are separated by the blood brain barrier (BBB) and are independently regulated [9] . Brain cells maintain cholesterol homeostasis by regulation of cholesterol synthesis Physiology & Behavior 168 (2017) [11] [12] [13] [14] [15] [16] [17] [18] [19] and cholesterol uptake through apolipoprotein E (ApoE)-related receptors [9, 10] .
The transport and redistribution of cholesterol in CNS cells are due to the lipoproteins presents in the cerebrospinal fluid [11] . The ApoE, richly present in brain lipoproteins appears to be involved in the transfer of cerebral cholesterol, cholesterol is transferred from enriched regions to regions with small quantities of cholesterol [12] . Cholesterol is synthesized in situ in the brain and a small quantity is present in the plasma. Cerebral renewal can occur by conversion of cholesterol to oxysterols; the compounds that can cross the BBB [12] . However, the Poloxamer-407 (P407) is a ubiquitous artificial surfactant and non-ionic detergent, that across the BBB [13, 14] . It was observed that P407 induced the hyperlipidemia in experimental animals after parenteral administration [15] . Typically, cholesterol and triglycerides increase within 36 h, of a single intraperitoneal injection of 500 mg/kg of P407. Poloxamer-407-induced hypertriglyceridemia and hypercholesterolemia are welldocumented phenomena. Hypertriglyceridemia is characterized by elevation in triglyceride levels and are attributed to inhibition of lipoprotein lipase while hypercholesterolemia was linked to indirect stimulation of the activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG CoA reductase), the rate-limiting enzyme in cholesterol biosynthesis, and decreased low density lipoprotein (LDL) receptor expression in all synthesizing cholesterol cells [15] [16] [17] . Cholesterol regulates biophysical membrane properties such as fluidity, permeability, and rigidity. The interactions between cholesterol and polar phospholipids can lead to local increases in lipid order. This leads to the formation of dynamic membrane domains that contribute to the regulation of key cellular processes, such as receptor signaling, endocytosis and neurotransmission [18] [19] , which can give rise to mood and anxiety disorders [20] . A number of neurological disorders have been reported to share a common etiology of defective cholesterol metabolism in the brain [21] .
Acetylcholine (ACh) is a neurotransmitter that plays an important role in many functions of both the peripheral and central nervous systems [22] . ACh acts in the processes involved in learning, memory function, locomotor control and cerebral blood flow [23] [24] [25] [26] [27] . ACh levels in synaptic cleft are regulated by acetylcholinesterase (AChE) activity and have been shown to be implicated in cell proliferation [28] and neurite outgrowth [29] . Interestingly, AChE responds to various insults including oxidative stress, an important event that has been related to the pathogenesis and progression of a variety of CNS disorders [30] . Thus, this enzyme may be a target for the emerging therapeutic strategy to treat cognitive disorders caused by hyperlipidemia [31] .
Previous experimental investigations have suggested that guarana (Paullinia cupana) may increase metabolism of adipose tissue in rats thereby increasing lipolysis as a result of the activation of adenosine A1 receptors [32] and reduction of body weight [33] . Guarana is a rich source of caffeine, which may stimulate the metabolism and enhance thermogenesis by acting as an ergogenic agent, assisting in the degradation of lipids and prevention of atherosclerosis [34] . These positive effects may contribute immensely towards the reduction of risk factors for cardiovascular diseases and improve cognitive functions [35, 36] . Leite et al. [37] also reported the presence of high concentration of polyphenols including tannins, flavonoids, and catechins and linked the antioxidant actions to these polyphenols [38] . In addition, guarana may exert several other properties including hypotensive, hypocholesterolemic and anti-inflammatory effects [39] .
Since hyperlipidemia is a major risk factor in the development of cognitive dysfunction related memory loss and guarana has been reported for acts in the improvement of cognitive ability and has neuroprotective effects. However, the possible mechanism involved in its neuroprotection has not been fully understood. It is therefore necessary to evaluate the possible preventive therapeutic mechanism of guarana on memory and anxiogenic-like behavior as well as AChE activity and biochemical parameters in hyperlipidemia rat model.
Material and methods

Chemicals
Acetylthiocholine iodide, 5,5′-dithio-bis-2-nitrobenzoic acid (DTNB), Coomassie Brilliant Blue G, Caffeine and Poloxamer-407 were obtained from Sigma Chemical Co. (St. Louis, MO,USA). Powdered P. cupana seed was produced and supplied by EMBRAPA (Brazilian Corporation of Agricultural Research). The detailed description and determination of the main bioactive compounds present in guarana used in this study were reported by Bittencourt et al. [40] . The main compounds present in guarana powder (xanthines and catechins) have been analyzed by chromatography (caffeine = 3.754 mg/g, theobromine = 2.065 mg/g, total catechins = 1.330 mg/g, and condensed tannins = 6.747 mg/g). All chemicals used in this experiment had analytical grade and highest purity.
Animals
Adult male heterogenic Wistar rats (70-90 days; 220-300 g) from the Central Animal House of the Federal University of Santa Maria (UFSM) were used in this experiment. The animals were maintained at a constant temperature (23 ± 1°C) on a 12 h light/dark cycle with free access to food and water. All animal procedures were approved by the Animal Ethics Committee (protocol under number: 114/2014).
Experimental procedure
The rats used in this study were randomly divided into twelve groups that received guarana in doses of 12.5, 25 and 50 mg/kg, caffeine 0.2 mg/kg, human equivalent dose of simvastatin, will serve as a comparative standard, and saline (0.9% NaCl). Group 1; normal rat administered saline (N + S), group 2; normal rat administered 12.5 mg/kg of guarana (N + 12.5), group 3; normal rat administered 25 mg/kg of guarana (N + 25), group 4; normal rat administered 50 mg/kg of guarana (N + 50), group 5; normal rat administered 0.2 mg/kg of caffeine (N + Caf), group 6; normal rat administered simvastatin 0.04 mg/kg (N + Sim), group 7; hyperlipidemic rat administered saline (H + S), group 8; hyperlipidemic rat administered 12.5 mg/kg of guarana (H + 12.5), group 9; hyperlipidemic rat administered 25 mg/kg of guarana (H + 25), group 10; hyperlipidemic rat administered 50 mg/kg of guarana (H + 50), group 11; hyperlipidemic rat administered 0.2 mg/kg of caffeine (H + Caf) and group 12; hyperlipidemic rat administered simvastatin 0.04 mg/kg (H + Sim). Guarana powder, caffeine and saline were administered by oral gavage once a day for a period of 30 days. The doses of guarana administered were based on the previous work from our research group [41] . The caffeine concentration chosen was equivalent to detected in the highest dose of guarana. To ascertain the effects of guarana powder and caffeine in experimental animal model, the equivalent dose of guarana powder and caffeine in rats and humans was calculated according to the method described by Reigner and Blesch [42] . Eq. (1) To induce hyperlipidemia, 500 mg/kg of Poloxamer-407 (dissolved in sterile NaCl 0.9% solution) was administered by a single intraperitoneal injection [17] . The non-hyperlipidemic rat groups received the same volume of vehicle (sterile 0.9% NaCl solution). After induction of hyperlipidemia, the groups destined to receive simvastatin were administered the dose of simvastatin by oral gavage. The simvastatin administered rat groups received only saline before induction. After 36 h of induction, the animals with higher values of total cholesterol and triglycerides levels when compared to the reference values [16] were subjected to training and behavioral parameter estimation. After the 32 days of experiment, the animals were anesthetized with isoflurane and euthanized, blood was collected by cardiac puncture. The cerebral cortex, hippocampus, striatum, hypothalamus and cerebellum were collected for the subsequent enzymatic assays (Fig. 1 ).
Separation of blood serum
Animals were anesthetized with isoflurane, and blood was collected through cardiac puncture. Blood samples were collected in tubes without anticoagulant, and after clot formation, they were centrifuged at 3000 rpm for 15 min at room temperature. The resultant serum samples were aliquoted in microtubes and kept on ice for subsequent measurements.
Biochemical parameters
Serum levels of glucose, total cholesterol, high-density lipoprotein cholesterol (HDL-C), triglycerides, aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), albumin, creatinine and uric acid were evaluated in a semi-automatic analyzer (TPAnalyzer Plus®, Thermoplate) using commercial kits (Labtest® Diagnóstica S.A.). Tests were carried out in duplicate. The low-density lipoprotein cholesterol (LDL-C) level was calculated using the formula of Friedewald [43] .
Brain tissue preparation
The cranium was opened; the structures were gently removed, separated into the cerebral cortex, hippocampus, striatum, hypothalamus and cerebellum. The brain structures were homogenized in a glass potter in a solution of 10 mM Tris-HCl, with pH 7.4, on ice, at a proportion of 1:10 (w/v). The resulting homogenate was centrifuged at 1800 rpm for 10 min and the resulting supernatant was used to determine AChE activity.
AChE assay
The AChE assay was determined as previously described [44] with a modification of the spectrophotometric method as previously described by Rocha et al. [45] . The reaction mixture (2 ml final volume) contained 100 mM K + -phosphate buffer, with pH 7.5 and 1 mM 5,5′-dithiobisnitrobenzoic acid (DTNB). The method is based on the formation of the yellow anion, 5,5′-dithio-bis-acid nitrobenzoic, measured by absorbance at 412 nm during 2 min of incubation at 25°C. The enzyme was pre-incubated for 2 min. The reaction was initiated by adding 0.8 mM acetylthiocholine iodide (AcSCh). The protein content was adjusted for each structure: cerebral cortex (0.8 mg/ml), hippocampus (0.8 mg/ml), striatum (0.4 mg/ml), hypothalamus (0.6 mg/ml) and cerebellum (0.6 mg/ml). All samples were analyzed in triplicate and the specific activity of the enzyme was expressed in μmol SCh/h/mg of protein.
Protein determination
Protein content was determined colorimetrically according to the method of Bradford [46] using bovine serum albumin (1 mg/ml) as standard solution.
Behavioral procedure 2.9.1. Object recognition task
After thirty days of treatment with guarana, caffeine or vehicle in rats; the animals were subjected to the object recognition memory task after 12 h of induction hyperlipidemia and 24 h before the euthanasia of the rat. The object recognition memory task was carried out in order to evaluate the short-term memory. An object recognition task was carried out according to the method previously described by Gomes et al. [47] . The task was performed in a 30 × 30 × 30 cm wooden chamber, with walls painted black, a front wall made of Plexiglas and a floor covered with ethyl vinyl acetate sheet. A light bulb, hanging 60 cm above the behavioral apparatus, provided constant illumination of about 40 lx, and an air-conditioner provided constant background sound isolation. The objects used were plastic mounting bricks, each with different shape and colors, but the same size. Throughout the experiments, objects used were arranged in a counterbalanced manner. Animals had not previously displayed a preference for any of the objects. Chambers and objects were cleaned with 30% ethanol immediately before and at the end of each behavioral evaluation. The task consisted of habituation, training, and testing sessions, each lasting 10 min. In the first session, rats were individually habituated to the behavioral apparatus and then returned to their home cages. Twenty-four hours later, the animals were subjected to a training session in which the animals were exposed to two of the same objects (object A), and the exploration time was recorded with two stopwatches. Exploration was recorded when the animal touched or reached the object with the nose at a distance of b2 cm. Climbing or sitting on the object was not considered exploration. The test session was carried out 4 h after training. Rats were placed back in the behavioral chamber and one of the familiar objects (object A) was replaced by a novel object (object B). The time spent exploring the familiar and the novel object was recorded. The discrimination index was then calculated; taking into account the difference in time spent exploring the new and familiar objects, using the Eq. (2):
The discrimination index was used as a memory parameter.
Elevated plus maze task
Anxiolytic-like behavior was evaluated using the elevated plus maze task as previously described [48, 49] . The apparatus consisted of a wooden structure raised to 50 cm from the floor. This apparatus was composed of 4 arms of the same size, with two enclosed arms (walls of 40 cm) and two open arms. Initially, the animals were placed on the central platform of the maze in front of an open arm. The animal had 5 min to explore the apparatus. The time spent and the numbers of entries in open and enclosed arms were recorded. The apparatus was thoroughly cleaned with 30% ethanol between each session.
Statistical analysis
The data were analyzed by one or two-way analysis of variance (ANOVA). Post hoc analyses were carried out by the Newman-Keuls multiple comparison test and F test for simple effect when indicated. P b 0.05 was considered to represent a significant difference. All data were expressed as mean ± standard error of the mean.
Results
Biochemical parameters
The result obtained for the glucose, total cholesterol, LDL-C, HDL-C, triglycerides, AST, ALT, ALP, albumin, creatinine and uric acid levels in both normal and hyperlipidemic rats administered guarana, caffeine or simvastatin are shown in Table 1 . A significant increase [F (5,72) = 7.44 for pretreatment; P b 0.001; n = 7] in total cholesterol was observed in H + S (559%) group when compared to N + S group. However, there were significant reductions (P b 0.05) in total cholesterol levels of rats in H + 25 (17%), H + 50 (41%), H + Caf (20%) and H + Sim (47%) groups when compared to H + S group. It is important to note that no significant (P N 0.05; n = 7) change in total cholesterol was observed between H + 25 and H + Caf groups as well as between H + 50 and H + Sim groups. In addition, significant elevations [F (5,72) = 26.69 for pretreatment; P b 0.001; n = 7] in LDL-C were observed in all hyperlipidemia-induced groups: H + S (754%), H + 12.5 (609%), H + 25 (537%), H + 50 (361%), H + Caf (470%) and H + Sim (372%) when compared to N + S group. Similar result pattern was observed for total cholesterol in that no significant difference (P N 0.05) in LDL-C was observed between H + 25 and H + Caf groups as well as between H + 50 and H + Sim groups. A significant increase [F (5,72) = 1.08 for pretreatment; P b 0.001; n = 7] in triglycerides was observed in H + S (1124%) group when compared to N + S group. Furthermore, there were no significant (P N 0.05; n = 7) differences in other biochemical parameters such as glucose, albumin, creatinine and uric acid in serum between hyperlipidemic and normal rat groups.
Hepatic enzyme activities
Our measurements of hepatic enzyme activity are presented in Table 2 Glucose (mg/dL); TC: total cholesterol (mg/dL); LDL-C: low-density lipoprotein-cholesterol (mg/dL) HDL-C: high-density lipoprotein-cholesterol (mg/dL); Tri: triglycerides (mg/dL); Albumin (g/dL); creatinine (mg/dL); uric acid (mg/dL). The results were analyzed using two-way ANOVA-Newman-Keuls multiple comparison test and expressed as mean ± S.E.M. ⁎ The value is significantly different from normal rats plus saline group (P b 0.05, n = 7). ⁎⁎ The value is significantly different from normal rats plus saline group (P b 0.01, n = 7). ⁎⁎⁎ The value is significantly different from normal rats plus saline group (P b 0.001, n = 7).
indices between H + 50 and H + Sim when compared with N + S group. However, H + 12.5 (22.37 ± 9.90), H + 25 (38.92 ± 8.59) and H + Caf (34.43 ± 7.41) groups, significantly (P b 0.05) prevented the hyperlipidemia induced in rats, in comparison to the N + S group. Guarana (12.5, 25, 50 mg/kg), caffeine and simvastatin without hyperlipidemia did not show any significant (P N 0.05) effect compared to N + S group (data not shown). Fig. 3 shows the effect of guarana, caffeine and simvastatin on the anxiolytic-like behavior in hyperlipidemic rats placed in the elevated plus-maze task. Statistical analysis of testing (one-way ANOVA followed by the Newman-Keuls multiple comparison post-hoc test) showed that the hyperlipidemic rats spent a same time in open arms and performed the same number of entries in the open arms when compared to rats of the other groups. This indicates that hyperlipidemia induced with P-407 may not cause anxiogenic effect (Fig. 3A and B) . In a similar manner, there was no alteration in the number of entries in the enclosed arms by hyperlipidemic rats when compared to the animals in other groups tested. This indicates that hyperlipidemia may not impair locomotor activity in this test (Fig. 3C) . Guarana (12.5, 25, 50 mg/kg), caffeine and simvastatin per se showed no significant change in the evaluated parameters compared to N + S group (data not shown).
Effect of guarana, caffeine and simvastatin in hyperlipidemic rats on anxiolytic-like behavior
Guarana prevented the alterations in AChE activity in the hippocampus induced by hyperlipemia
The results obtained for AChE activity in different brain structures of hyperlipidemic rats treated with guarana, caffeine and simvastatin are presented in Fig. 4 . There were no significant (P N 0.05) differences in the cerebral cortex, hypothalamus, striatum and cerebellum AChE activities between all the rat groups (Fig. 4A, C, D and E) . However, the AChE activity was significantly [F (5, 72) = 60.88; P b 0.05; n = 7] decreased (60%) in the hippocampus of H + S group when compared to normal groups. However, pretreatment with 12.5, 25 and 50 mg/kg of guarana, caffeine and the treatment with simvastatin in hyperlipidemic rats significantly increased AChE activity when compared to H + S group AST: aspartate transaminase (U/L), ALT: alanine transaminase (U/L); ALP: alkaline phosphatase (U/L). The results were analyzed using two-way ANOVA-Newman-Keuls multiple comparison test and expressed as mean ± S.E.M. ⁎⁎⁎ The value is significantly different from normal rats plus saline group (P b 0.001, n = 7). (P b 0.05). Only guarana 50 mg/kg and simvastatin groups were able to significantly (P b 0.01) prevent and reverse, respectively, the decreased AChE activity in hyperlipidemia. It is worth noting that the treatment with caffeine and 50 mg/kg of guarana the same effect on hyperlipidemic groups (Fig. 4B) . As observed, AChE activity was not modified by guarana, caffeine and simvastatin per se treatment in all the brain structures.
Discussion
In this study, we evaluate the possible preventive effect of guarana in memory and anxiogenic-like behavior as well as AChE activity and biochemical parameters in hyperlipidemia-induced rats. Our results revealed that guarana powder was able to reduce the levels of TC and LDL-C in a manner similar to simvastatin and partially reduced the liver damage caused by hyperlipidemia. Guarana was able to prevent changes in the activity of AChE and improve memory impairment due to hyperlipidemia.
The observed elevations in TC, LDL-C and triglycerides levels in hyperlipidemic group in this study, confirm the efficacy of induction. It is worth noting that P-407 has the ability to cross the BBB, hence its adverse effect on the structure and function of the brain has been well documented [13, 14] . The mechanisms by P-407 induce hypertriglyceridemia and hypercholesterolemia include the inhibition of lipoprotein lipase, stimulation of 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase activity and reduction of low density lipoprotein receptor (LDLr) expression in all synthesizing cholesterol cells [15] [16] [17] .
As observed in this study, pretreatment with guarana powder and caffeine as well as treatment with simvastatin in hyperlipidemic state, showed significant reductions in TC and LDL-C levels when compared to the hyperlipidemic group without pretreatment (H + S). This may indicate possible preventive effect of guarana powder and caffeine against the alterations caused by hyperlipidemia. This result corroborates with data from the literature where cholesterol was lowered and LDL-C levels reduced by guarana powder in humans [39] . In this experiment, both the caffeine as simvastatin were used as standard compound and drug respectively. Their effects were subsequently compared with guarana powder. Caffeine at the dose tested (0.2 mg/kg) was also able to reduce the levels of cholesterol and LDL-C but not in the same proportion as 50 mg/kg of guarana. These results may be due to the presence of methylxanthines in guarana. The lipolytic effects of methylxanthines such as caffeine, theophylline and theobromine are well defined and characterized. Methylxanthines act by activating sterol regulatory element binding protein (SREBP), which is a transcription factor bound to membranes that regulates major cholesterol biosynthesis. In animals, SREBP controls the transcription of the HMG-CoA reductase and LDL receptor genes to avoid a sharp increase in TC and LDL-C levels [50] . The difference in the effect of the same concentration of caffeine and guarana, was documented in our previous investigation [41] and was possibly due to the presence of other methylxanthines, besides the caffeine, in guarana. In a similar manner, simvastatin used as a standard in this study, was able to lower cholesterol and LDL levels of hyperlipidemic rats. The reduction by simvastatin was similar to that of the highest dose of guarana, when compared to the hyperlipidemic group. Simvastatin is a lipophilic statin, and crosses the blood-brain barrier more readily than less lipophilic statins such as pravastatin, fluvastatin and rosuvastatin. The hydrolyzed simvastatin may in turn enter the brain through carrier-mediated transport and selectively acts by inhibiting HMG-CoA reductase in cholesterol biosynthesis in the liver and in the brain [51] .
Concerning hepatic enzymes, the increased serum ALT, AST and ALP activities in hyperlipidemic groups are in agreement with findings from the work reported of Sheneni et al. [52] , which indicated that disorders in lipoprotein metabolism may potentially be accompanied by hepatic injury. The accumulation of triglycerides and other fats in the liver cells may thus contribute to elevations in serum ALT, AST and ALP activity in P-407 treated rats [52] . In relation to the hepatic enzymes, we found increased ALP activity in all hyperlipidemic groups, except in H + Sim. ALT activity was increased in all of hypercholesterolemic groups, but the groups pretreated with guarana powder, caffeine and treated with simvastatin showed a slight decrease in this hepatic enzyme activity when compared with H + S group. AST activity was altered only in H + S and H + 12.5 groups. Aminotransferases and ALP are normally found in circulation in small amounts because of hepatic growth and repair. In clinical examination, the increased levels of these enzyme activities in serum are well known biomarkers for liver damage. Nevertheless, approximately 80% of AST in hepatocytes appears to be located in the mitochondria, whereas ALT is thought to be predominantly non-mitochondrial. ALT has been implicated in mild hepatocellular injury, in which there is disruption of the plasmatic membrane of hepatocytes but the mitochondrial membrane is not damaged [53] .
Our results have revealed that P-407-induced hyperlipidemia can damage both the plasmatic and mitochondrial membrane. However, pretreatment with guarana and caffeine, as well as treatment with simvastatin may prevent and/or reduce mitochondrial level damage; possibly due to reduction in cholesterol accumulation in the liver cells, once this accumulation promotes the production of free radicals and the oxidative stress plays an essential role in the hepatic injury [54] . Guarana and caffeine has properties antioxidants, reducing free radicals and decreasing the damage generated [55] [56] .
The novel object recognition task has been used for evaluating memory function in rodents [44] . As observed in this study, the significant decrease in the recognition index of hyperlipidemic rats may suggest possible impairment of short-term memory function. This result corroborates with published data where hyperlipidemia induced by the intraperitoneal administration of poloxamer resulted into cognitive impairment [57] . Other studies have linked high cholesterol to damage of the BBB with corresponding impairments in hippocampal-dependent memory tasks [58] .
However, pretreatment of hyperlipidemic rats with highest dose of guarana (H + 50 group) in this study, resulted into the recognition index that was similar to that of the N + S group. These findings indicate that treatment with guarana may prevent memory impairment induced by hyperlipidemia. Hyperlipidemic rats pretreated with caffeine (H + Caf), and guarana (H + 50), showed significant elevations in recognition indices when compared with the H + S group. This agrees with earlier study where improved memory function was reported when low doses of caffeine (0.2 to 20 mg/kg) were administered to rats and mice [59] . The short-term memory improvement of guarana may not be completely linked to caffeine; other components of guarana such as methylxanthines, may act in an additive manner. Although the mechanisms by which guarana enhances memory remain largely unclear, there are several possibilities. First, by blocking adenosine, methylxanthines presents in guarana can prevent it from inhibiting norepinephrine, which has positive effects on consolidation of memory [60] . Another possibility is that methylxanthines action in the hippocampus, which is highly enriched in adenosine A1 receptors [61] , enhances longterm potentiation in this subfield [62] , which may have a role in memory.
Furthermore, treatment of hyperlipidemic rats with simvastatin (H + Sim) also resulted into the recognition index similar to the N + S group, showing improvement in memory, having multiple effects besides lowering cholesterol, which may contribute to alteration in memory performance such as inhibition of dimerization of β-secretase, alterations in multiple gene expression patterns, and alteration in the activity of various neurotransmitters [63] .
After the session of novel object recognition, animals were subjected to elevated plus-maze task and anxiogenic-like behavior was evaluated. Our results showed that the hyperlipidemia induced with P-407 did not significantly alter the time spent in open arms, number of entries in open arms and number of entries in enclosed arms between the rat groups. This suggests that neither hyperlipidemic rat groups nor the groups pretreated with guarana, caffeine nor treated with simvastatin per se was anxious; indicating that no anxiogenic-like behavior was observed in all the groups studied. This is in agreement with the assertion with a study on hypercholesterolemia where no significant difference was found among the groups in the elevated plus maze test, suggesting that elevated serum levels of cholesterol may not cause anxiogenic-like behavior [64] .
The effect of hyperlipidemia on the cholinergic system is another important aspect that was considered in this study. The cholinergic system plays a crucial role in regulating learning, memory, and cortical organization of movement [65] . Acetylcholinesterase (AChE) is a pivotal enzyme which hydrolyzes the neurotransmitter acetylcholine (ACh) in many tissues and responsible for modulating the cholinergic function [28] . In the present study, there was significant decrease in AChE activity in the hippocampus of hyperlipidemic rat group when compared with the normal control group. However, there were no significant differences in the AChE activity in the other brain structures including cerebral cortex, hypothalamus, striatum and cerebellum between all the groups. The results obtained agree in part, with that obtained by Gutierres et al. [66] where diet induced hypercholesterolemic rats had significantly reduced AChE activity in cerebral cortex and hippocampus synaptosomes. The non-significant difference in the AChE activity in cerebral cortex in this study may be attributed to the short exposure time (acute exposure) to P-407 for the development of hyperlipidemia (36 h) unlike the hypercholesterolemia induced by diet which took a longer period of 4 weeks to develop [67] . This shows that the hippocampus, due to a higher cholesterol concentration than other brain structures, responds more quickly to hyperlipidemia than other brain structures [68] . Changes in hippocampus-specific memory are seen in hyperlipidemia, as the effects on non-dependent memory tests hippocampus, showed no changes [69, 70] .
Cholesterol plays extensive role in cell membrane fluidization and facilitates transmembrane signaling by altering membrane function. These effects have been attributed to bulk lipid loading of the membrane, by direct interaction of cholesterol with the cell membrane resulting in disruption of the ability of the protein to undergo the conformational changes required for signaling [71] .
In the present study, hyperlipidemic rats showed a decrease in the AChE activity, and reduction of memory function. Rats fed a hypercholesterolemic diet showed a decrease in choline acyltransferase (ChAT) activity in neurons [72] , thereby leading to reduction in acetylcholine production in hippocampus. Possibly by having a small production of acetylcholine, the AChE activity is decreased, as a compensatory mechanism. Although this compensatory mechanism is not able to reverse the decreased cognitive ability. Pretreatment with guarana and caffeine in hyperlipidemic rats, may have led to maintenance of ChAT activity and subsequent normalization of acetylcholine levels, because guarana has methylxanthines, able to increase acetylcholine release into synapses, modulating directly the activity of AChE in hippocampus [73] to that similar to control group. Able to prevent memory loss and improve cognitive function in rats [74] and humans [75, 76] . In an attempt to confer neuroprotection, simvastatin may inhibit HMG-CoA reductase in cholesterol biosynthesis in the liver and in the brain [63] , alter neurotransmitter level, elevate AChE activity and improve memory and learning [62] .
In conclusion, these results may be due to the presence of methylxanthines in guarana. Methylxanthines controls the transcription of the genes for HMG-CoA reductase and the LDL receptor. Methylxanthines can prevent a sharp increase in TC and LDL-C levels. In the hippocampus, methylxanthines can increase acetylcholine release into synapses, thereby directly modulating the activity of AChE, which may reduce memory impairment in the brains of rats with induced hyperlipidemia. Furthermore, the induction of hyperlipidemia by P-407 did not trigger anxiolytic-like behavior in rats. This study has identified a significant difference in the modulatory effects of caffeine (same concentration present in the highest dose of guarana) and guarana. Although further study is required to validate the neuroprotective effect of guarana in the context of hyperlipidemia, guarana powder may be a source of promising phytochemicals that can be used as adjuvant therapy in the management of hyperlipidemia and cognitive disorders.
